Cargando…
MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer
Approximately 18% of ovarian cancers have an underlying genetic predisposition and many of the genetic alterations have become intervention and therapy targets. Although mutations in MutY homolog (MUTYH) are best known for MUTYH associated polyposis and colorectal cancer, it plays a role in the deve...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825630/ https://www.ncbi.nlm.nih.gov/pubmed/33419231 http://dx.doi.org/10.3390/diagnostics11010084 |